The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells
Open accessAbstract
Lymphomas arising from NK or γδ-T cells are very aggressive diseases and little is known regarding their pathogenesis. Here we report frequent activating mutations of STAT3 and STAT5B in NK/T-cell lymphomas (n=51), γδ-T-cell lymphomas (n=43) and their cell lines (n=9) through next generation and/or Sanger sequencing. STAT5B N642H is particularly frequent in all forms of γδ-T-cell lymphomas. STAT3 and STAT5B mutations are associated with increased phosphorylated protein and a growth advantage to transduced cell lines or normal NK cells. Growth-promoting activity of the mutants can be partially inhibited by a JAK1/2 inhibitor. Molecular modelling and surface plasmon resonance measurements of the N642H mutant indicate a marked increase in binding affinity of the phosphotyrosine-Y699 with the mutant histidine. This is associated with the prolonged persistence of the mutant phosphoSTAT5B and marked increase of binding to target sites. Our findings suggest that JAK-STAT pathway inhibition may represent a therapeutic strategy. NK-cell and γδ-T cell lymphoma share clinic-pathological features; however the driving mutations are largely unknown. Here the authors, using a combination of RNA-Seq analysis, targeted re-sequencing and functional analysis, identify frequent activating mutations in STAT3 and STAT5Bthat may be driver mutations in these diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,621
Comparative Protein Modelling by Satisfaction of Spatial Restraints
Šali, A., & Blundell, T. L. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1626 · Cited by 12,977
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R., Garimella, K. V., Maguire, J. R., Hartl, C., Philippakis, A. A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,456
An integrated map of genetic variation from 1,092 human genomes
The 1000 Genomes Project Consortium (2012) · Nature · doi:10.1038/nature11632 · Cited by 7,711
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
MolDock: A New Technique for High-Accuracy Molecular Docking
Thomsen, R., & Christensen, M. H. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051197e · Cited by 2,327
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
Schmitz, R., Young, R. M., Ceribelli, M., Jhavar, S., Xiao, W., Zhang, M., Wright, G., Shaffer, A. L., Hodson, D. J., Buras, E., et al. (2012) · Nature · doi:10.1038/nature11378 · Cited by 924
Self-citationClusPro: an automated docking and discrimination method for the prediction of protein complexes
Comeau, S. R., Gatchell, D. W., Vajda, S., & Camacho, C. J. (2004) · Bioinformatics · doi:10.1093/bioinformatics/btg371 · Cited by 855
Somatic STAT3 Mutations in Large Granular Lymphocytic Leukemia
Koskela, H. L. M., Eldfors, S., Ellonen, P., van Adrichem, A. J., Kuusanmäki, H., Andersson, E. I., Lagström, S., Clemente, M. J., Olson, T., Jalkanen, S. E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114885 · Cited by 777
Jaffe, E. S. (2009) · Hematology · doi:10.1182/asheducation-2009.1.523 · Cited by 632
Jerez, A., Clemente, M. J., Makishima, H., Koskela, H., LeBlanc, F., Peng Ng, K., Olson, T., Przychodzen, B., Afable, M., Gomez-Segui, I., et al. (2012) · Blood · doi:10.1182/blood-2012-06-435297 · Cited by 424
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma
Odejide, O., Weigert, O., Lane, A. A., Toscano, D., Lunning, M. A., Kopp, N., Kim, S., van Bodegom, D., Bolla, S., Schatz, J. H., et al. (2014) · Blood · doi:10.1182/blood-2013-10-531509 · Cited by 398
Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15.
Johnston, J. A., Bacon, C. M., Finbloom, D. S., Rees, R. C., Kaplan, D., Shibuya, K., Ortaldo, J. R., Gupta, S., Chen, Y. Q., & Giri, J. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8705 · Cited by 390
Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia
Rajala, H. L. M., Eldfors, S., Kuusanmäki, H., van Adrichem, A. J., Olson, T., Lagström, S., Andersson, E. I., Jerez, A., Clemente, M. J., Yan, Y., et al. (2013) · Blood · doi:10.1182/blood-2012-12-474577 · Cited by 294
Silva, M., Benito, A., Sanz, C., Prosper, F., Ekhterae, D., Nuñez, G., & Fernandez-Luna, J. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22165 · Cited by 277
Janus Kinase 3–Activating Mutations Identified in Natural Killer/T-cell Lymphoma
Koo, G. C., Tan, S. Y., Tang, T., Poon, S. L., Allen, G. E., Tan, L., Chong, S. C., Ong, W. S., Tay, K., Tao, M., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0028 · Cited by 275
Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia
Kiel, M. J., Velusamy, T., Rolland, D., Sahasrabuddhe, A. A., Chung, F., Bailey, N. G., Schrader, A., Li, B., Li, J. Z., Ozel, A. B., et al. (2014) · Blood · doi:10.1182/blood-2014-03-559542 · Cited by 255
Pardanani, A. (2008) · Leukemia · doi:10.1038/sj.leu.2404948 · Cited by 212
Iqbal, J., Kucuk, C., deLeeuw, R. J., Srivastava, G., Tam, W., Geng, H., Klinkebiel, D., Christman, J. K., Patel, K., Cao, K., et al. (2009) · Leukemia · doi:10.1038/leu.2009.3 · Cited by 200
Self-citationChan, J. K. C., Chan, A. C. L., Cheuk, W., Wan, S.-K., Lee, W.-K., Lui, Y.-H., & Chan, W.-K. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318222dfcd · Cited by 195
Self-citationPiva, R., Agnelli, L., Pellegrino, E., Todoerti, K., Grosso, V., Tamagno, I., Fornari, A., Martinoglio, B., Medico, E., Zamò, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.9759 · Cited by 165
Bouchekioua, A., Scourzic, L., de Wever, O., Zhang, Y., Cervera, P., Aline-Fardin, A., Mercher, T., Gaulard, P., Nyga, R., Jeziorowska, D., et al. (2014) · Leukemia · doi:10.1038/leu.2013.157 · Cited by 160
Self-citationIqbal, J., Weisenburger, D. D., Chowdhury, A., Tsai, M.-Y., Srivastava, G., Greiner, T. C., Küçük, C., Deffenbacher, K., Vose, J. M., Smith, L. M., et al. (2010) · Leukemia · doi:10.1038/leu.2010.255 · Cited by 151
Self-citationSTAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma
Kopp, K., Ralfkiær, U., Gjerdrum, L. M. R., Helvad, R., Pedersen, I. J., Litman, T., Jønson, L., Hagedorn, P., Krejsgaard, T., Gniadecki, R., et al. (2013) · Cell Cycle · doi:10.4161/cc.24987 · Cited by 147
PRDM1 is a tumor suppressor gene in natural killer cell malignancies
Küçük, C., Iqbal, J., Hu, X., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115128108 · Cited by 125
Self-citationSignaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency
Johnston, J. A., Bacon, C. M., Riedy, M. C., & O’Shea, J. J. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.60.4.441 · Cited by 109
Comprehensive review of JAK inhibitors in myeloproliferative neoplasms
Sonbol, M. B., Firwana, B., Zarzour, A., Morad, M. L., Rana, V., & Tiu, R. V. (2012) · Therapeutic Advances in Hematology · doi:10.1177/2040620712461047 · Cited by 98
Identification of STAT5A and STAT5B Target Genes in Human T Cells
Kanai, T., Seki, S. M., Jenks, J. A., Kohli, A., Kawli, T., Patacsil, D., Snyder, M. P., Bacchetta, R., & Nadeau, K. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086790 · Cited by 81
Frequent mutations of Fas gene in nasal NK/T cell lymphoma
Takakuwa, T., Dong, Z., Nakatsuka, S., Kojya, S., Harabuchi, Y., Yang, W., Nagata, S., & Aozasa, K. (2002) · Oncogene · doi:10.1038/sj.onc.1205571 · Cited by 78
Identification of HIF2α as an important STAT5 target gene in human hematopoietic stem cells
Fátrai, S., Wierenga, A. T. J., Daenen, S. M. G. J., Vellenga, E., & Schuringa, J. J. (2011) · Blood · doi:10.1182/blood-2010-08-303669 · Cited by 70
Ohgami, R. S., Ma, L., Merker, J. D., Martinez, B., Zehnder, J. L., & Arber, D. A. (2013) · Leukemia · doi:10.1038/leu.2013.104 · Cited by 69
The JAK inhibitor AZD1480 regulates proliferation and immunity in Hodgkin lymphoma
Derenzini, E., Lemoine, M., Buglio, D., Katayama, H., Ji, Y., Davis, R. E., Sen, S., & Younes, A. (2011) · Blood Cancer Journal · doi:10.1038/bcj.2011.46 · Cited by 67
HACE1 Is a Tumor Suppressor Gene Candidate in Natural Killer Cell Neoplasms
Küçük, C., Hu, X., Iqbal, J., Gaulard, P., Klinkebiel, D. L., Cornish, A. S., Davé, B. J., & Chan, W. C. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.09.012 · Cited by 55
Self-citationDonaldson, J. M., Zer, C., Avery, K. N., Bzymek, K. P., Horne, D. A., & Williams, J. C. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307309110 · Cited by 54
Self-citationOhgami, R. S., Ma, L., Monabati, A., Zehnder, J. L., & Arber, D. A. (2014) · Haematologica · doi:10.3324/haematol.2013.101543 · Cited by 43
STAT5 regulation of BCL10 parallels constitutive NFκB activation in lymphoid tumor cells
Nagy, Z. S., LeBaron, M. J., Ross, J. A., Mitra, A., Rui, H., & Kirken, R. A. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-67 · Cited by 33
Cited by
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Swerdlow, S. H., Campo, E., Pileri, S. A., Harris, N. L., Stein, H., Siebert, R., Advani, R., Ghielmini, M., Salles, G. A., Zelenetz, A. D., et al. (2016) · Blood · doi:10.1182/blood-2016-01-643569 · Cited by 7,831
The ClusPro web server for protein–protein docking
Kozakov, D., Hall, D. R., Xia, B., Porter, K. A., Padhorny, D., Yueh, C., Beglov, D., & Vajda, S. (2017) · Nature Protocols · doi:10.1038/nprot.2016.169 · Cited by 3,310
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Johnson, D. E., O'Keefe, R. A., & Grandis, J. R. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.8 · Cited by 3,110
Campo, E., Jaffe, E. S., Cook, J. R., Quintanilla-Martinez, L., Swerdlow, S. H., Anderson, K. C., Brousset, P., Cerroni, L., de Leval, L., Dirnhofer, S., et al. (2022) · Blood · doi:10.1182/blood.2022015851 · Cited by 1,608
Self-citationCytokines in Cancer Immunotherapy
Waldmann, T. A. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028472 · Cited by 507
Metadata
- Authors
- Küçük, C., Jiang, B., Hu, X., Zhang, W., Chan, J. K. C., Xiao, W., Lack, N., Alkan, C., Williams, J. C., Avery, K. N., Kavak, P., Scuto, A., Sen, E., Gaulard, P., Staudt, L., Iqbal, J., Zhang, W., Cornish, A., Gong, Q., Yang, Q., Sun, H., d’Amore, F., Leppä, S., Liu, W., Fu, K., de Leval, L., McKeithan, T., & Chan, W. C.
- Venue
- Nature Communications
- Published
- 2015-01-14
- Volume
- 6
- Issue
- 1
- Pages
- 6025-6025
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W1977198374
- Cited by
- 393
- References
- 37
- FWCI
- 31.66
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.